Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Why it was recalled
Cross Contamination with Other Products
What was recalled
Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-009-13
Recalling firm
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
NDC code
59148-009-13
Origin
N/A, Japan
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0468-2024
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.